Gilead Sciences Quad Study 102 Results Conference Call on Wednesday, March 7, 2012
March 06 2012 - 4:35PM
Business Wire
Gilead Sciences, Inc. (Nasdaq:GILD) announced today that the
Quad Study 102 results will be presented on a conference call on
Wednesday, March 7, at 1:30 p.m. Pacific Time, 4:30 p.m. Eastern
Time. The conference call and slides will be accessible via the
internet from the company’s website.
To access the webcast link, log on to www.gilead.com. Please
connect to the company’s website at least 15 minutes prior to the
conference call to ensure adequate time for any software download
that may be required to listen to the webcast. Alternatively,
please call 1-866-788-0541 (U.S.) or 1-857-350-1679 (international)
and dial the participant passcode 57882166 to access the call.
Telephone replay will be available approximately two hours after
the call through 11:59 p.m. Eastern Time, March 10, 2012. To access
the replay, please call 1-888-286-8010 (U.S.) or 1-617-801-6888
(international) and dial the participant passcode 14598403. The
webcast will be archived on www.gilead.com for 14 days following
the call.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of
patients suffering from life-threatening diseases worldwide.
Headquartered in Foster City, California, Gilead has operations in
North America, Europe and Asia Pacific.
For more information on Gilead Sciences, please
visit www.gilead.com or call the Gilead Public Affairs Department
at 1-800-GILEAD-5 (1-800-445-3235).
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jul 2023 to Jul 2024